17 In mice, experimental influenza virus infection stimulates CD8 T cell infiltration of the airways.
7 146 The cannula is secured on the stage with a support that holds it in position, so it is correctly aligned 147 with the trachea. It is held in place with 2 screws that prevent it from moving in transport, or during 148 the attachment of the respirator. The forepaws are secured to the stage with surgical tape to 149 maintain position of the mouse body on the stage. A few drops of saline are placed on the 150 exposed tracheal tissue to prevent drying.
151
152 Maintaining blood O2 saturation and temperature: The cannula is quickly attached to a Harvard 153 Inspira Advanced Safety Ventilator, and both 100% O2 and 0.5% isofluorane flow is started, 154 according to mouse weight. The MouseOX Plus thigh sensor is attached to the exposed thigh 155 and monitoring is begun immediately. Oxygenation levels are maintained at 95% and heart rate 156 ranges between 250 and 600 beats per minute. The rectal body-temperature is continuously 157 monitored and maintained using a small animal temperature controller that is connected to a rectal 158 probe and a feedback-regulated rodent heating pad. After achieving stable physiology, and 159 verification of lack of both pedal and palpebral reflex, the pancuronium bromide (0.4 mg/kg) is 160 administered, based on body weight. The saline covering the exposed trachea is blotted away 161 and replaced with 0.05% agarose to seal the exposed area. Once the agarose is solidified, a 162 support ring is placed over the imaging area and covered with a piece of plastic wrap.
163 Approximately 5 ml of water is pooled over the imaging area to submerse the objective.
164
165 Humane end point: Imaging is performed with the animals fully sedated as described above. At 166 the end of an imaging session, which last one to two hours, all animals are euthanized by 167 increasing isofluorane dose and ceasing respiratory support. The animal's heartbeat is continually 168 measured, and the animal is considered euthanized when the heart stops beating. This occurs 169 within one to five minutes after imaging has stopped. The numbers of animals used are indicated 170 in the figure legends for each set of data. 213 If the T cells are responding to chemokine signals that direct them towards the infected epithelium 214 on days 6-8, then we would predict that interference with these signals would result in delayed 215 migration to the airway surfaces. We therefore developed a computational approach to measure 216 the depth of the T cells in the trachea relative to the airway surface. The measurements were 217 conducted from days 6-9 of infection. In the control mice, T cell abundance closest to the airways 218 peaked on day 7 and actually decreased on days 8 and 9 ( Figure 2 ). Consistent with the 12 238 compared to untreated and isotype treated controls but had little effect on the confinement indices 239 ( Figure 3C ). For unknown reasons, the isotype control affected cell motility parameters on day 9, 240 but not on other days. The anti-pMHC treatment still further reduced all parameters on day 9 241 compared to either the isotype or untreated controls. These results suggest TCR engagement 242 with pMHC has a role governing the motility behavior of the T cells, possibly by further activating 243 the cells in the tissue. 14 249 Re-introduction of antigen: We reasoned that the changes on day 9 were the result of a 250 significant reduction in signals received from ABC as the virus is cleared [9]. To address this, we 251 re-introduced antigen in the form of soluble SIINFEKL peptides on days 8 and 9. The introduction 252 of peptides had no effect on motility parameters on day 8 when virus and, presumably, ABC are 253 still abundant. However, on day 9, the introduction of peptides resulted in significantly decreased 254 velocities and displacement, increased numbers of cells arrested, and heightened confinement 255 compared to vehicle controls ( Figure 4A-C) . This is consistent with the results of pMHC blocking 256 on day 8, and strongly suggests that the balance of antigen signals in the presence of continued 257 chemokine signaling result marked changes in velocity and confinement that occur between day 258 8 and day 9. This is consistent with the interpretation that the still highly activated T cells switch 259 to a rapid surveillance of the surrounding cells for the presence of virus or residual antigen and 260 ABC. 16 280 narrow in cross section, and there is dense extracellular matrix underlying the epithelial surface), 281 high CXCL9 and CXCL10 chemokine concentrations at the epithelium, which can contribute to 282 arrest, and presumably engagement with antigen bearing cells in the form of either APC or 283 infected targets. This is discussed further below. 284 285 On day 9 when virus is cleared, the CD8 T cells normally exhibit an increase in cell velocities, and 286 yet remain confined. Imaging of this behavior shows rapid extension and retraction of T cell 287 protrusions, but little distance traveled (compare Supplemental Movies S1 and S2). We have 288 interpreted this collective behavior as rapid surveillance for residual antigen and virus by the 289 highly activated effector T cells. Treatment with Ptx at this time point significantly decreased all 290 the motility parameters, suggesting a requirement for GPCR signals for optimal surveillance of 291 the tissue as the infection resolves. How chemokines and chemokine receptors affect changes to 292 T cell motility on day 9 is unresolved. The chemokines CXCL9 and CXCL10 are expressed 293 constitutively by airway epithelium, and increase during infection [25, 26] . In addition to potentially 294 providing chemotactic and chemokinetic signals, they may be needed for integrin activation [27], 295 each of which could contribute to the cell behavior we observe, though we have not formally tested 296 these mechanisms in our model.
298
The experiments blocking MHC with specific monoclonal antibodies showed significant effects on 299 CD8 T cell motility. However, the effects were not entirely as expected. If we take the hypothesis 300 that engaging antigen bearing cells will cause cells to arrest, at least briefly, as has been observed 301 in other T cell motility studies [28], then we would predict that blocking antigen signals would 302 partially or completely reverse cell arrest. On day 6 there were no differences in the motility 303 parameters between pMHC mAb treated mice and isotype control mice, likely because few T cells 304 had found their targets. But on days 7-9, velocities were consistently reduced with pMHC mAb 305 treatment, with greatest magnitude of the effect on day 8, a time when we expect maximal
